Expression of citrullinated GRP78 in vivo was confirmed through the detection of the citrullinated GRP78 189-208 peptide by mass spectrometry in tumour lysates and this was demonstrated at a level greater than other citrullinated epitopes already shown to be targets in B16 melanoma (17–19). This evidence concerns the gene HSPA5 and neoplasm.